• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-122 结合位点插入/缺失多态性与白细胞介素-1α 3'非翻译区易感性相关,导致肝细胞癌。

An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma.

机构信息

Laboratory of Cellular and Molecular Tumor Immunology, Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, Medical College, Soochow University, Suzhou 215123, Jiangsu, People's Repubic of China.

出版信息

Carcinogenesis. 2009 Dec;30(12):2064-9. doi: 10.1093/carcin/bgp283.

DOI:10.1093/carcin/bgp283
PMID:19917630
Abstract

Hepatocellular carcinoma (HCC) is the fifth most common malignancy caused by environmental and genetic factors. MicroRNAs (miRNAs) are a class of short non-coding RNAs with posttranscriptional regulatory functions. They participate in diverse biological pathways and function as gene regulators. Genetic polymorphisms in 3' untranslated regions (3' UTRs) targeted by miRNAs alter the strength of miRNA binding, with consequences on regulation of target genes thereby affecting the individual's cancer risk. We have previously predicted polymorphisms falling in miRNA-binding regions of cancer genes. We selected an insertion/deletion (Indel) polymorphism (rs3783553) in the 3' UTR of interleukin (IL)-1alpha (IL1A) for a case-control study in a Chinese population. With samples from 403 HCC patients and 434 healthy control individuals, strong evidence of association was observed for the variant homozygote. This association was validated in a second independent case-control study with 1074 HCC patients and 1239 healthy control individuals (odds ratio = 0.62; 95% confidence interval = 0.49-0.78). We further show that the 'TTCA' insertion allele for rs3783553 disrupts a binding site for miR-122 and miR-378, thereby increasing transcription of IL-1alpha in vitro and in vivo. These findings suggest that functional polymorphism rs3783553 in IL1A could contribute to HCC susceptibility. Considering IL-1alpha affects not only various phases of the malignant process, such as carcinogenesis, tumor growth and invasiveness, but also patterns of interactions between malignant cells and the host's immune system, our results indicated that IL-1alpha may be a promising target for immunotherapy, early diagnosis and intervention of HCC.

摘要

肝细胞癌(HCC)是由环境和遗传因素引起的第五种最常见的恶性肿瘤。微小 RNA(miRNA)是一类具有转录后调控功能的短非编码 RNA。它们参与多种生物途径,并作为基因调节剂发挥作用。miRNA 靶 3'非翻译区(3'UTR)的遗传多态性改变了 miRNA 结合的强度,从而影响靶基因的调节,进而影响个体的癌症风险。我们之前预测了 miRNA 结合区癌症基因的多态性。我们选择了白细胞介素(IL)-1alpha(IL1A)3'UTR 中的插入/缺失(Indel)多态性(rs3783553)进行中国人群的病例对照研究。在 403 例 HCC 患者和 434 例健康对照个体的样本中,观察到该变体纯合子与疾病强烈相关。在第二个独立的 HCC 病例对照研究中,对 1074 例 HCC 患者和 1239 例健康对照个体进行了验证(比值比=0.62;95%置信区间=0.49-0.78)。我们进一步表明,rs3783553 的'TTCA'插入等位基因破坏了 miR-122 和 miR-378 的结合位点,从而增加了体外和体内 IL-1alpha 的转录。这些发现表明,IL1A 中的功能性多态性 rs3783553 可能导致 HCC 易感性。由于 IL-1alpha 不仅影响恶性过程的各个阶段,如癌变、肿瘤生长和侵袭性,还影响恶性细胞与宿主免疫系统之间的相互作用模式,我们的结果表明,IL-1alpha 可能是 HCC 免疫治疗、早期诊断和干预的有前途的靶点。

相似文献

1
An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma.miRNA-122 结合位点插入/缺失多态性与白细胞介素-1α 3'非翻译区易感性相关,导致肝细胞癌。
Carcinogenesis. 2009 Dec;30(12):2064-9. doi: 10.1093/carcin/bgp283.
2
A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.IL-1α 3'UTR中miRNA-122结合位点的一个功能性变体可预测口咽癌的风险和HPV阳性肿瘤。
Eur J Cancer. 2015 Jul;51(11):1415-23. doi: 10.1016/j.ejca.2015.04.016. Epub 2015 May 14.
3
An insertion/deletion polymorphism at miRNA-122 binding site in the IL1A is associated with a reduced risk of cervical squamous cell carcinoma.白细胞介素1α(IL1A)中微小RNA-122结合位点的插入/缺失多态性与宫颈鳞状细胞癌风险降低相关。
Genet Test Mol Biomarkers. 2015 Jun;19(6):331-4. doi: 10.1089/gtmb.2015.0015. Epub 2015 May 8.
4
An insertion/deletion polymorphism in the interleukin-1A 3'untranslated region confers risk for gastric cancer.白细胞介素-1A 3'非翻译区的插入/缺失多态性会增加患胃癌的风险。
Cancer Biomark. 2016;16(3):359-65. doi: 10.3233/CBM-160574.
5
Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.白细胞介素-1α基因上miRNA-122结合位点多态性及其与乙型肝炎病毒突变的相互作用与肝细胞癌风险的关联。
Front Med. 2014 Jun;8(2):217-26. doi: 10.1007/s11684-014-0326-2. Epub 2014 Apr 21.
6
Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.SGSM3基因3'非翻译区插入/缺失多态性与肝细胞癌风险的关联。
Tumour Biol. 2014 Jan;35(1):295-301. doi: 10.1007/s13277-013-1039-x. Epub 2013 Aug 6.
7
A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.白细胞介素-1α 3'非翻译区中微小RNA-122结合位点的功能性变体可预测口咽癌患者的复发风险。
Oncotarget. 2016 Jun 7;7(23):34472-9. doi: 10.18632/oncotarget.8908.
8
A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.一个位于前 microRNA-196a-2 的功能性多态性与土耳其人群肝细胞癌易感性相关:一项病例对照研究。
J Viral Hepat. 2011 Jul;18(7):e399-407. doi: 10.1111/j.1365-2893.2010.01414.x. Epub 2010 Dec 23.
9
No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.miR-146a 前体 rs2910164 多态性与土耳其人群肝癌发展风险之间无关联:一项病例对照研究。
Gene. 2011 Oct 15;486(1-2):104-9. doi: 10.1016/j.gene.2011.07.006. Epub 2011 Jul 23.
10
Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population.HLA-G 3'UTR 14-bp 插入/缺失多态性与中国人群肝癌易感性的关联。
DNA Cell Biol. 2011 Dec;30(12):1027-32. doi: 10.1089/dna.2011.1238. Epub 2011 May 25.

引用本文的文献

1
The genomic landscape of the immune system in lung cancer: present insights and continuing investigations.肺癌中免疫系统的基因组格局:当前见解与持续研究
Front Genet. 2024 Jun 25;15:1414487. doi: 10.3389/fgene.2024.1414487. eCollection 2024.
2
Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities.探讨循环 miRNA 作为骨关节炎诊断和预后生物标志物的可行性:挑战与机遇。
Int J Mol Sci. 2023 Aug 24;24(17):13144. doi: 10.3390/ijms241713144.
3
Investigation of UTR Variants by Computational Approaches Reveal Their Functional Significance in Gene Regulation.
通过计算方法研究 UTR 变异体揭示了它们在基因调控中的功能意义。
Genes (Basel). 2023 Jan 18;14(2):247. doi: 10.3390/genes14020247.
4
Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease.前神经降压素作为检测非酒精性脂肪性肝病的潜在新型诊断生物标志物。
Diabetes Metab Syndr Obes. 2022 Jun 22;15:1935-1943. doi: 10.2147/DMSO.S365147. eCollection 2022.
5
The Immunogenetics of Alopecia areata.斑秃的免疫遗传学。
Adv Exp Med Biol. 2022;1367:19-59. doi: 10.1007/978-3-030-92616-8_2.
6
Associations between genetic variations in microRNA and myocardial infarction susceptibility: a meta-analysis and systematic review.miRNA 基因变异与心肌梗死易感性的关联:荟萃分析和系统评价。
Herz. 2022 Dec;47(6):524-535. doi: 10.1007/s00059-021-05086-3. Epub 2021 Dec 8.
7
Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.免疫基因组景观分析肝癌预后免疫相关基因。
J Healthc Eng. 2021 Oct 29;2021:3761858. doi: 10.1155/2021/3761858. eCollection 2021.
8
An SNP reducing SNORD105 and PPAN expression decreases the risk of hepatocellular carcinoma in a Chinese population.SNP 降低 SNORD105 和 PPAN 表达可降低中国人群患肝细胞癌的风险。
J Clin Lab Anal. 2021 Dec;35(12):e24095. doi: 10.1002/jcla.24095. Epub 2021 Nov 5.
9
piRNAs in Gastric Cancer: A New Approach Towards Translational Research.piRNAs 在胃癌中的作用:转化研究的新途径。
Int J Mol Sci. 2020 Mar 19;21(6):2126. doi: 10.3390/ijms21062126.
10
MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma.乙型肝炎及乙型肝炎病毒相关肝细胞癌患者中的微小RNA-122
J Gastrointest Oncol. 2019 Aug;10(4):789-796. doi: 10.21037/jgo.2019.02.14.